NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 211 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,911 | -22.2% | 17,165 | +2.9% | 0.01% | -16.7% |
Q2 2023 | $424,056 | -21.1% | 16,682 | +12.2% | 0.01% | -25.0% |
Q1 2023 | $537,587 | -7.2% | 14,871 | +1.6% | 0.01% | -11.1% |
Q4 2022 | $579,506 | +36.0% | 14,634 | +60.0% | 0.01% | +12.5% |
Q3 2022 | $426,000 | -30.8% | 9,149 | -34.9% | 0.01% | -20.0% |
Q2 2022 | $616,000 | -30.5% | 14,060 | +14.8% | 0.01% | -23.1% |
Q1 2022 | $886,000 | -1.7% | 12,246 | +10.1% | 0.01% | +8.3% |
Q4 2021 | $901,000 | -49.3% | 11,118 | -27.2% | 0.01% | -52.0% |
Q3 2021 | $1,778,000 | -32.2% | 15,272 | -3.5% | 0.02% | -32.4% |
Q2 2021 | $2,624,000 | +29.7% | 15,829 | +9.1% | 0.04% | +19.4% |
Q1 2021 | $2,023,000 | -16.3% | 14,506 | +3.9% | 0.03% | -22.5% |
Q4 2020 | $2,417,000 | +20.4% | 13,960 | -3.2% | 0.04% | +2.6% |
Q3 2020 | $2,008,000 | +30.4% | 14,416 | +11.9% | 0.04% | +21.9% |
Q2 2020 | $1,540,000 | +65.9% | 12,888 | +38.9% | 0.03% | +39.1% |
Q1 2020 | $928,000 | -23.1% | 9,277 | -9.6% | 0.02% | -8.0% |
Q4 2019 | $1,206,000 | +19.8% | 10,264 | -12.4% | 0.02% | +13.6% |
Q3 2019 | $1,007,000 | +56.1% | 11,718 | +17.8% | 0.02% | +57.1% |
Q2 2019 | $645,000 | +15.6% | 9,949 | +11.4% | 0.01% | +7.7% |
Q1 2019 | $558,000 | +393.8% | 8,930 | +206.5% | 0.01% | +333.3% |
Q4 2018 | $113,000 | +61.4% | 2,914 | +281.4% | 0.00% | +50.0% |
Q3 2017 | $70,000 | +20.7% | 764 | -1.5% | 0.00% | 0.0% |
Q2 2017 | $58,000 | +176.2% | 776 | +248.0% | 0.00% | +100.0% |
Q1 2017 | $21,000 | – | 223 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |